FDA Vaccine Agency Leadership

News

Trump Administration Releases New COVID-19 Vaccine Plan

FDA Plans to Limit COVID-19 Vaccines to High-Risk Groups

In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the Center for Biologics Evaluation and research at the FDA, and Dr. Martin Makary, FDA commissioner, explained their plan for how the FDA will evaluate and recommend COVID-19 vaccines going forward.

Opinion

MSNBC on MSN · 8h

What the FDA’s new Covid vaccine policy is really about

It began in 2020 with a coordinated push to generate public backlash to lockdowns. The ultimate aim was restoring normalcy, ending a politically and economically inconvenient crisis. Over time, however, the campaign expanded to include more wedges — the virus’ origins, school closures, mask mandates and, of course, vaccines.

U.S. News & World Report · 2d

Trump Administration Releases New COVID-19 Vaccine Plan: What to Know

In a major policy shift, federal health officials anticipate the shots will be made available to adults 65 and older as well as children and younger adults who have one or more risk factors that make them more vulnerable to severe COVID-19.

16don MSN

US FDA names agency critic Vinay Prasad as top vaccine official

The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...

NBC263h

FDA advisory committee meets on COVID-19 vaccine after putting new restrictions on approvals

The vaccine advisory committee for the Food and Drug Administration met Thursday to discuss potential changes to the formula for COVID-19 vaccines for 2025-2026.

23d

FDA chief says they're looking at whether to approve COVID shots for next winter

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

3hon MSN

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be ...

Yahoo Finance9d

FDA’s future in MAHA hands: How leadership is changing the agency’s trajectory

Here, we take a look at who’s in at the FDA, who’s out, and what could be next for the agency’s leadership ... navigating the future of the FDA’s vaccine division at a time when HHS ...

13hon MSN

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results